Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
China-CHAMP: Atropine sulfate for myopia progression in children
NCT06209320Phase 3Active, not recruiting
- Sponsor
- Zhaoke Ophthalmology
- Start
- Mar 2022
- Primary completion
- Mar 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of Myopine in myopia, sponsored by Zhaoke Ophthalmology. Started Mar 2022; status: active, not recruiting.
02
Drugs
Myopine
03
Conditions
myopia
Beyond the preview
Go deeper on NCT06209320.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06209320.